You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Moodys
Merck
Colorcon
Boehringer Ingelheim
McKinsey

Last Updated: December 1, 2020

DrugPatentWatch Database Preview

Drugs in Development Information for CP1-1189

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What is the development status for investigational drug CP1-1189?

CP1-1189 is an investigational drug.

There have been 4 clinical trials for CP1-1189. The most recent clinical trial was a Phase 2 trial, which was initiated on July 1st 2009.

The most common disease conditions in clinical trials are Leukemia, Leukemia, Myeloid, and Leukemia, Myelogenous, Chronic, BCR-ABL Positive. The leading clinical trial sponsors are Sheba Medical Center, H. Lee Moffitt Cancer Center and Research Institute, and National Cancer Institute (NCI).

Recent Clinical Trials for CP1-1189
TitleSponsorPhase
A Single Intravenous Dose Study of E3112 in Japanese Healthy Adult Male SubjectsEA Pharma Co., Ltd.Early Phase 1
Nilotinib Pre and Post Allogeneic Stem Cell TransplantationSheba Medical CenterPhase 2
Treatment of CML Patients With Imatinib and Hydroxyurea (CML2004)University of LeipzigPhase 1/Phase 2

See all CP1-1189 clinical trials

Clinical Trial Summary for CP1-1189

Top disease conditions for CP1-1189
Top clinical trial sponsors for CP1-1189

See all CP1-1189 clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Moodys
Merck
Colorcon
Boehringer Ingelheim
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.